Orizon Valorizacao de Residuos SA: Swaps of Upsides with Vital — Reiterate Buy, Increasing PT
Report Coverage
- Broker
- UBS
- Region
- Brazil
- Sector
- Utilities, Real Estate
- Report Type
- Company Report
- Primary Focus
- Orizon's strategic transformation through the Vital merger and biomethane scale-up into a tariff-anchored waste management platform
Report Summary
UBS raises Orizon's price target to R$97/share (from R$92) and reiterates Buy, incorporating the Vital merger (expected to close by end-2Q26 after CADE approval) and positive earnings revisions from LRCAP auction wins. The merged entity offers a more defensive, tariff-anchored earnings profile with one of the highest real IRRs in UBS's coverage at 12%.
Key Takeaways
- Vital merger expected to close by end-2Q26 after CADE approval; Vital brings a more defensive, tariff-anchored business model (86.5% of gross profit from Integrated Management) with 5.5 mn tons disposed and R$520 mn EBITDA in FY2025
- Biomethane business enters its first full operating year at scale in 2026, with Paulínia and Jaboatão plants online plus Vital's GBio pipeline adding Macaúbas (90,000 m³/day), Ecourbis II (20,000 m³/day), and Juiz de Fora (30,000 m³/day)
- Valuation at 9x EV/EBITDA on 2027E EBITDA yields R$97/share PT; stock has rallied 16% since Vital announcement but still offers 12% real IRR, one of the highest in UBS's Brazil coverage
Why This Report Matters
Orizon's merger with Vital creates Brazil's largest integrated waste management platform, combining landfill operations with biomethane production and tariff-anchored municipal concessions. The pivot toward predictable, inflation-linked revenue streams and multiple monetization layers on the same infrastructure represents a structural upgrade in earnings quality for Brazilian waste sector investors.
Topics Covered
Companies Mentioned
Who this summary is for
This summary is for users researching the UBS Orizon Valorizacao de Residuos SA report. It helps users review Orizon Valorizacao de Residuos SA: Swaps of Upsides with Vital — Reiterate Buy, Increasing PT coverage, key takeaways, and related broker or sector research paths across Waste management, Biomethane expansion, M&A integration; Orizon Valorizacao de Residuos SA, Vital.
Related Search Paths
Use these links to find similar broker research summaries and sector report notes.